期刊文献+

解剖性部分肺叶切除术治疗3336例肺结节患者的疗效 被引量:18

Anatomical partial lobectomy for the treatment of 3336 cases of patients with lung nodule
原文传递
导出
摘要 目的探讨解剖性部分肺叶切除术的可行性、安全性和有效性。方法回顾性分析2013年11月至2019年11月于中国医学科学院肿瘤医院行解剖性部分肺叶切除术的3336例肺结节患者的临床病理资料。依据肿瘤切缘距离确定靶肺组织范围后,将区域内累及的主要血管、支气管行解剖性离断,沿切割平面切除靶肺组织,完成解剖性亚肺叶切除和系统性淋巴结清扫或采样。结果3336例肺结节患者中,多发肺结节668例,孤立性肺结节2668例。术后病理为良性283例,浸润前病变1197例(不典型腺瘤样增生38例,原位腺癌445例,微小浸润性腺癌714例),浸润性腺癌1713例,非腺癌73例,转移性癌70例。1786例浸润性原发肺癌患者中,11例行术前新辅助治疗,术后病理分期为ypⅠA期;1775例未行新辅助治疗,TNM分期为ⅠA期1587例,ⅠB期112例,ⅡA期3例,ⅡB期18例,ⅢA期37例,ⅢB期9例,Ⅳ期9例。手术时间为(127.3±55.3)min,术后住院时间为(4.8±2.4)d,≥3级并发症发生率为1.1%(38/3336),术后30 d无死亡患者。结论解剖性部分肺叶切除术具有较好的临床可行性,同时兼顾了安全性和有效性,值得在临床推广应用。 Objective To explore the feasibility,safety and effectiveness of anatomical partial lobectomy.Methods The clinical data of 3336 patients with lung nodules underwent anatomical partial lobectomy in our center from November 2013 to November 2019 were retrospectively analyzed.We set the safety margin distance according to the imaging feature of the lesion.The surgeons then anatomically detached the major vessels and bronchus in this region,resected the targeted lung tissue along the plane,and completed the resection of anatomical pulmonary lobe and clean and sampling of systemic lymph nodules.Results A total of 668 cases were multiple nodules and 2668 cases were solitary pulmonary nodules.According to the postoperative pathological results,283 cases were benign,1197 cases were preinvasive lesions(including 38 cases of atypical adenomatous hyperplasia,445 cases of adenocarcinoma in situ and 714 cases of minimally invasive adenocarcinoma),1713 cases were invasive adenocarcinoma,73 cases were non-adenocarcinoma and 70 cases were metastatic carcinoma.Among 1786 invasive primary lung cancers,11 cases received preoperative neoadjuvant chemotherapy,and their postoperative pathologic diagnoses were stage ypIA.Other 1775 cases who did not receive postoperative neoadjuvant treatment included 1587 cases in stageⅠA,112 cases in stageⅠB,3 cases in stageⅡA,18 cases in stageⅡB,37 cases in stageⅢA,9 cases in stageⅢB,9 cases in stageⅣ.The average operation time was(127.3±55.3)minutes,and the mean postoperative hospital stay was(4.8±2.4)days.The incidence rate of complications(grade>2)was 1.1%(38/3336),and no death occurred during 30 days after operation.Conclusion Anatomic partial lobectomy has good clinical applicability,safety and effectiveness,which is worthy of clinical application and recommendation.
作者 邱斌 冀瑛 张帆 彭岳 高禹舜 谭锋维 牟巨伟 薛奇 高树庚 赫捷 Qiu Bin;Ji Ying;Zhang Fan;Peng Yue;Gao Yushun;Tan Fengwei;Mou Juwei;Xue Qi;Gao Shugeng;He Jie(Department of Thoracic Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
机构地区 国家癌症中心
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2021年第1期137-142,共6页 Chinese Journal of Oncology
基金 国家重点研发计划(2017YFC1308700) 院校基本科研业务(2018PT32033) 协和医学院研究生创新基金课题(2019-1002-53)。
关键词 非小细胞肺 解剖性部分肺叶切除术 微创手术 Neoplasms,non-small cell lung Anatomical partial lobectomy Minimally invasive surgery
  • 相关文献

参考文献5

二级参考文献32

  • 1薛青青,许晶,何志成,吴卫兵.改良式双胸管引流在肺癌微创手术中的应用[J].南京医科大学学报(自然科学版),2019,39(12):1755-1757. 被引量:4
  • 2初向阳,孙玉鹗,黄孝迈.局限性肺切除在肺癌治疗中的作用[J].中华胸心血管外科杂志,1996,12(4):209-210. 被引量:20
  • 3Hwang Y,Kang CH,Kim HS,et al. Comparison of thoracoscopicsegmentectomy and thoracoscopic lobectomy on the patients withnon-small cell lung cancer: a propensity score matching study [J].Eur J Cardiothoracic Surg, 2015,48(2) :273-278.
  • 4Zhong C, Fang W, Mao T,et al. Comparison of thoracoscopicsegmentectomy and thoracoscopic lobectomy for small-sized stageI A lung cancer[ J]. Ann Thorac Surg, 2012,94(2) ;362-367.
  • 5Ren M, Meng Q, Zhou W, et al. Comparison of short-term effectof thoracoscopic segmentectomy and thoracoscopic lobectomy for.the solitary pulmonary nodule and early-stage lung cancer [ J ].Onco Targets Ther, 2014, 7:1343-1347.
  • 6Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomyversus limited resection for T1 NO non-small cell lung cancer.Lung Cancer Study Group[ J]. Ann Thorac Surg, 1995,60(3):615-622.
  • 7Nakamura H, Kawasaki N, Taguchi M, et al. Survival followinglobectomy vs limited resection for stage I lung cancer: a meta-analysis[ J]. Br J Cancer, 2005,92(6) : 1033-1037.
  • 8Fan J, Wang L, Jiang GN, et al. Sublobectomy versus lobectomyfor stage I non-small-cell lung cancer, a meta-analysis ofpublished studies[ J]. Ann Surg Oncol, 2012,19(2) :661-^68.
  • 9Zhang Y, Sun Y, Wang R, et al. Meta-analysis of lobectomy,segmentectomy,and wedge resection for stage I non-small cell lungcancer[ J]. J Surg Oncol, 2015,111(3) : 334-340.
  • 10Keenan RJ, Landreneau RJ, Maley RH, et al. Segmentalresection spares pulmonary function in patients with stage I lungcancer[ J]. Ann Thorac Surg, 2004, 78(1) :228-233.

共引文献142

同被引文献201

引证文献18

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部